乳清苷结构式
|
常用名 | 乳清苷 | 英文名 | Orotidine |
---|---|---|---|---|
CAS号 | 314-50-1 | 分子量 | 288.211 | |
密度 | 1.8±0.1 g/cm3 | 沸点 | N/A | |
分子式 | C10H12N2O8 | 熔点 | 200ºC | |
MSDS | 美版 | 闪点 | N/A |
乳清苷用途Orotidine 是 DNA 和 RNA 的嘧啶核苷酸合成过程中的一个中间产物,在现代生物中起到重要作用。 |
中文名 | 乳清苷 |
---|---|
英文名 | orotidine |
中文别名 | 血苷 | 脲啶-6-羧酸 |
英文别名 | 更多 |
描述 | Orotidine 是 DNA 和 RNA 的嘧啶核苷酸合成过程中的一个中间产物,在现代生物中起到重要作用。 |
---|---|
相关类别 | |
靶点 |
Human Endogenous Metabolite |
参考文献 |
密度 | 1.8±0.1 g/cm3 |
---|---|
熔点 | 200ºC |
分子式 | C10H12N2O8 |
分子量 | 288.211 |
精确质量 | 288.059357 |
PSA | 162.08000 |
LogP | -1.24 |
折射率 | 1.678 |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危险品运输编码 | NONH for all modes of transport |
海关编码 | 2934999090 |
海关编码 | 2934999090 |
---|---|
中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途 |
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Pyrophosphate interactions at the transition states of Plasmodium falciparum and human orotate phosphoribosyltransferases.
J. Am. Chem. Soc. 132(25) , 8787-94, (2010) Orotate phosphoribosyltransferases from Plasmodium falciparum and human sources (PfOPRT and HsOPRT) use orotidine as a slow substrate in the pyrophosphorolysis reaction. With orotidine, intrinsic kine... |
|
The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease.
J. Inherit. Metab. Dis. 22(2) , 174-84, (1999) Thirty-three children ranging from 2 weeks to 12 years of age were selected for allopurinol loading, 16 on the basis of an increased urinary ourotate excretion detected by routine organic acid analysi... |
|
Orotidine accumulation in human erythrocytes during allopurinol therapy: association with high urinary oxypurinol-7-riboside concentrations in renal failure and in the Lesch-Nyhan syndrome.
Clin. Sci. 80(3) , 191-7, (1991) 1. A compound identified as orotidine has been found in the erythrocytes of all subjects on allopurinol. 2. The erythrocyte orotidine concentrations were much higher in patients with renal failure or ... |
UNII:B350MC02GZ |
3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid |
1,2,3,6-Tetrahydro-2,6-dioxo-3-b-D-ribofuranosyl-4-pyrimidinecarboxylic Acid |
6-Carboxyuridin |
3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-2,6-diketo-pyrimidine-4-carboxylic acid |
Uridine-6-carboxylic acid |
3-b-D-Ribofuranosylorotic Acid |
Orotidine |
Uridine, 6-carboxy- |
Orotidine (Uridine-6-carboxylic acid) |
6-Carboxyuridine |
URIDIN-6-CARBOXYLIC ACID |